Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linerixibat with Metformin in Type 2 Diabetes
NCT02202161Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linerixibat in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Aug 2014; status: completed.
02
Drugs
linerixibat
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02202161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02202161.